MedPath

Gemfibrozil

Gemfibrozil Tablets, USPRev. 12/10

Approved
Approval ID

b57eeb99-679e-4136-80f4-85421e21400b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 4, 2011

Manufacturers
FDA

Med-Health Pharma, LLC

DUNS: 962603812

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Gemfibrozil

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51138-588
Application NumberANDA077836
Product Classification
M
Marketing Category
C73584
G
Generic Name
Gemfibrozil
Product Specifications
Route of AdministrationORAL
Effective DateJuly 4, 2011
FDA Product Classification

INGREDIENTS (10)

CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
GEMFIBROZILActive
Quantity: 600 mg in 1 1
Code: Q8X02027X3
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
METHYLCELLULOSE (1500 MPA.S)Inactive
Code: P0NTE48364
Classification: IACT
HYPROMELLOSE 2910 (15000 MPA.S)Inactive
Code: 288VBX44JC
Classification: IACT
POLYETHYLENE GLYCOLSInactive
Code: 3WJQ0SDW1A
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Gemfibrozil - FDA Drug Approval Details